| NCT Number | NCT03523221 |
| Lead Sponsor | Hamad Medical Corporation |
| Conditions | Anaphylaxis |
| Enrollment | 210 participants |
| Start Date | 2018-04-15 |
| Primary Completion | 2024-12 (estimated) |
| Study Completion | 2024-12 (estimated) |
| Updated on ClinicalTrials.gov | 2024-08-14 |